Heterologous protection against influenza by injection of DNA encoding a viral protein.
about
Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinMolecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageProtection against malaria by immunization with plasmid DNA encoding circumsporozoite proteinDNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculationsPreferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunizationPotent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsAntigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitopeGene vaccination with naked plasmid DNA: mechanism of CTL primingProtective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunizationAlphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.Detection of progeny immune responses after intravenous administration of DNA vaccine to pregnant miceTumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccinesRole of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibitionDNA immunization as a technology platform for monoclonal antibody inductionDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadA Blueprint for HIV Vaccine DiscoveryUniversal immunity to influenza must outwit immune evasionSynthetic DNA vaccine strategies against persistent viral infectionsEnhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexesIntradermal electroporation of naked replicon RNA elicits strong immune responsesExpression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in miceInduction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes.Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed miceEvaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccinesDNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic miInoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c MiceAntigen processing and presentation by a murine myoblast cell lineDNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidImmune responses to plasmid DNA encoding the hepatitis C virus core proteinProphylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.Vaccines: the Fourth CenturyDNA vaccine for cancer immunotherapyAdjuvant activity of CpG oligodeoxynucleotidesMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesAnti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors
P2860
Q24514954-25B12163-F177-4DEA-BB52-9FBF97E4633FQ24531303-4942DE7C-767C-4ABB-9F78-48AD0C25F113Q24531468-B943BE20-108A-45C8-8C73-4843BB6CBB29Q24563514-8DD2394F-F24A-4182-9441-7A8FF66F0271Q24563751-AD23C4C1-57D4-4EF7-9DC1-78F61033E3A7Q24599495-F02849C6-5A70-408C-8949-0C5A92F89BB2Q24646818-C643C797-BAF3-47C9-905D-A7C400EC5492Q24648051-F653B27B-1A47-48D1-A41B-F1746AF309C8Q24652858-FF31F73F-C666-4E01-857B-D6C94302261AQ24676957-13A4002E-6751-4A11-B4B9-9FF786EFCB14Q24676991-C173D5E8-4DE9-4236-8414-43B0C5D1A4FFQ24796792-A661B251-80E1-4FDD-9F23-0D4136375676Q24797322-B0FC0AC2-89BE-4A90-9347-20B2852EE0D1Q24804837-6BE6650D-7EFB-4A47-BE43-21629A5DAD84Q24806858-71CB1A11-3702-4DD7-9E27-9B5C4C9DE177Q26751432-67246104-88DA-4625-B2C4-9B983E6E69B1Q26783897-C4879386-4CA9-49A8-9FC8-F54422C65906Q26829865-E334CE17-B168-411A-B25B-F4D048288C18Q26991896-F6262E46-6A09-4E4C-B2A6-84C0B37D5737Q27016078-4757EA24-79BD-4909-BDF1-3F5E8DD2989BQ27309096-E3E11CF2-29C0-4EC2-AFD3-707FBF0B3248Q27310340-601A8FD9-76DC-43E4-AF97-8F97E7C54E97Q27469367-A54431D8-C249-4E5C-8ACF-C84F8B4B732CQ27469515-6079E06F-A141-4C91-99D9-420001D3C31AQ27469568-A1215A69-F2B1-4C39-88B6-8BBBF6C8DB45Q27469642-2159ED3E-0BB2-41C1-849D-2194FC75B84EQ27469682-D21FC975-E59B-4D9D-9214-2C64A99012BBQ27469698-2313CDEB-DF5A-4DE5-AEA6-360E2B09C66FQ27469754-2CD64CE5-BA98-43D1-AD70-02E2AB9CD9BCQ27473069-1549D1DD-9E4F-4945-9C91-592D1173D7FDQ27473373-43FEDA34-5A7F-4E18-8A06-A8D007E153C4Q27473532-B40FF989-4B1D-4732-AFAE-97C36ED3350EQ27480298-CBC621FF-EF45-4044-907E-9C8FA1A401C8Q27480300-D5201140-D22E-4BCC-8874-86FD390A35FBQ27488288-8C8A6608-8638-4988-8DC5-C0513A119BAFQ27490454-72E1A654-1457-44A2-84E3-48A630A61992Q28080919-DCB6772F-7076-4BD1-A7BD-28FF52E7CD80Q28250104-5C302349-DC02-4B78-BFE8-491AE81D47BCQ28294355-5D7B96EB-359B-409C-8626-E05B91E787EFQ28378984-9318C42A-E9A3-4FCE-8C87-A42611AA4EE2
P2860
Heterologous protection against influenza by injection of DNA encoding a viral protein.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@en
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@nl
type
label
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@en
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@nl
prefLabel
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@en
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@nl
P2093
P356
P1433
P1476
Heterologous protection against influenza by injection of DNA encoding a viral protein.
@en
P2093
Donnelly JJ
Felgner PL
Friedman A
Gromkowski SH
P304
P356
10.1126/SCIENCE.8456302
P407
P577
1993-03-01T00:00:00Z